Drug Companies, Prescribers Endanger Patients by Routinely Flouting FDA Rules, Senate Probe Finds

Share this story

A patient prepares to take mifepristone, the first medication in a medical abortion, at the Alamo Womenโ€™s Clinic in Carbondale, Ill., April 20, 2023.

Evelyn Hockstein/Reuters

Drug companies producing chemical abortion pills and the online prescribers they provide those drugs to routinely fail to comply with U.S. Food and Drug Administration (FDA) safeguards, an extensive investigation by Senate Republicans found.

Major drug companies sell large quantities of chemical abortion pills to telemedicine companies, which then prescribe those drugs to women without first ensuring that the drugs will be used according to FDA guidelines, according to an investigative report released Thursday by the Senate Health, Education, Labor, and Pensions (HELP) Committee.

Kamden Mulder

About the Author

Kamden Mulder

Kamden Mulder is a William F. Buckley Jr. Fellow in Political Journalism. She is a graduate of Hillsdale College.

Comments

Advertisement

Advertisement